Ying Huang, Legend Biotech CEO
August 12, 2024 11:55 AM EDT
Pharma
Cell/Gene Tx
Manufacturing

Leg­end con­tin­ues Carvyk­ti fac­to­ry builds to ce­ment CAR-T ter­ri­to­ry with J&J

Anna Brown

News Reporter

Leg­end Biotech says it plans to fur­ther boost Carvyk­ti man­u­fac­tur­ing as the com­pa­ny and its part­ner John­son & John­son look to stay ahead in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times